Trial Profile
Improvement of gastrointestinal symptoms taking Rebamipide in type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Sep 2016 New trial record